Pharmacokinetics

Related publications (723)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Pharmacokinetics

Graph Chatbot

Chat with Graph Search

Optimised three-dimensional in vitro retinoblastoma models tailored for drug discovery and clinical translatability

Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care

Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy

Development of stimuli-responsive chemistry for tumor-targeted immunotherapy

Alchemical analysis of FDA approved drugs

The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma

Elucidating and modulating regulatory pathways so as to reprogram the immunosuppressive tumor microenvironment for therapeutic benefit

Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework

From Surfactants to Viscoelastic Capsules

Development of cyclic peptides that can be administered orally to inhibit disease targets